Interleukin-17A Antagonist
9 drugs across 2 manufacturers|0 Generic,9 Brand
Total Drugs
9
0G / 9B
Manufacturers
2
Avg $6375.0984/unit
Avg 7d Change
0.00%
Across 0 drugs with changes
7d Activity
9 flat
of 9 total drugs
Class Price Trend
Monthly average NADAC price per unit, split by generic and brand
Manufacturer Breakdown
2 manufacturers producing drugs in this therapeutic class
| Drug ↕ | Price | 7d Change ↕ |
|---|---|---|
COSENTYX 150 MG/ML SYRINGE secukinumab | $7923.3134 per ML | — |
COSENTYX SENSOREADY 150 MG/ML PEN secukinumab | $7874.0281 per ML | — |
TALTZ 80 MG/ML AUTOINJECTOR (2-PACK) ixekizumab | $7435.8708 per ML | — |
TALTZ 80 MG/ML SYRINGE ixekizumab | $7402.0679 per ML | — |
TALTZ 80 MG/ML AUTOINJECTOR (3-PACK) ixekizumab | $7371.1393 per ML | — |
TALTZ 80 MG/ML AUTOINJECTOR ixekizumab | $7347.5448 per ML | — |
COSENTYX UNOREADY 300 MG/2 ML PEN (1 PEN) secukinumab | $4105.5041 per ML | — |
COSENTYX (150 MG/ML) 300 MG DOSE-2 SYRINGES secukinumab | $3965.6440 per ML | — |
COSENTYX SENSOREADY 300 MG DOSE/2 PENS (150 MG/PEN) secukinumab | $3950.7728 per ML | — |